Aboleris Pharma
5 known investors
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
Founders & leadership
IA
Ignacio AnegonCo-founder, Senior Consultant & SAB Member
CG
Carole GuillonneauinCo-founder & Head of Research
FH
François-Xavier HubertCo-founder, Past President & Board Member
Investors · 5
Frequently asked questions
- What does Aboleris Pharma do?
- AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
- Who founded Aboleris Pharma?
- Aboleris Pharma was founded by Ignacio Anegon, Carole Guillonneau, François-Xavier Hubert.
- Who are Aboleris Pharma's investors?
- Aboleris Pharma's investors include Criteria Bio Ventures, Newton Biocapital, Sound Bioventures, Sambrinvest, Wallonie Entreprendre.